Very informative and well educated Dr
Trial Structure Duration: 48 weeks of treatment Participants: 338 adults randomized 2:1:1:1:1:2:2 to placebo or retatrutide groups Doses tested: 1mg, 4mg, 8mg, 12mg (all with slow titration from 2mg starting dose) Lifestyle intervention: All participants received counseling on diet (500 kcal/day deficit) and exercise (150 min/week) Primary endpoint: Percent weight change at 24 weeks Key secondary endpoints: Weight change at 48 weeks, proportion achieving 5%, 10%, 15% loss The trial used a slow titration protocol to minimize side effects: all groups except the 1mg dose started at 2mg weekly and escalated every 4 weeks
Research Applications Retatrutide has become an important investigational peptide in metabolic research because of its ability to activate the GLP-1, GIP, and glucagon receptor pathways simultaneously
Weve reviewed over 20 online GLP-1 providers and found 7 that wont break the bank AND will provide you with amazing care to help you achieve your weight-loss goals
For comprehensive long-term safety data including side effect patterns at 80104 weeks, see our long-term safety analysis